750 KRW
23.92 B KRW
526.95 B KRW
11.62 M
About DAEWON PHARMACEUTICAL
Sector
Headquarters
Seoul
Founded
1958
Website
ISIN
KR7003220001
FIGI
BBG000C194Q7
Daewon Pharmaceutical Co., Ltd. engages in the production and sale of pharmaceutical products. It offers multivitamins, antipyretics, analgesics and anti-inflammatory, gastrointestinal, endocrine, antimicrobial, psychoneurotic, respiratory, cardiovascular and neuromuscular drugs. The company was founded by Boo-Hyeon Baek on January 7, 1958 and is headquartered in Seoul, South Korea.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 003220 is 14,250 KRW — it has decreased by −1.41% in the past 24 hours. Watch DAEWON PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DAEWON PHARMACEUTICAL stocks are traded under the ticker 003220.
003220 stock has fallen by −0.64% compared to the previous week, the month change is a −5.73% fall, over the last year DAEWON PHARMACEUTICAL has showed a −7.77% decrease.
We've gathered analysts' opinions on DAEWON PHARMACEUTICAL future price: according to them, 003220 price has a max estimate of 18,000.00 KRW and a min estimate of 18,000.00 KRW. Watch 003220 chart and read a more detailed DAEWON PHARMACEUTICAL stock forecast: see what analysts think of DAEWON PHARMACEUTICAL and suggest that you do with its stocks.
003220 reached its all-time high on Jul 24, 2020 with the price of 29,960 KRW, and its all-time low was 1,210 KRW and was reached on Oct 28, 2003. View more price dynamics on 003220 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
003220 stock is 3.61% volatile and has beta coefficient of 0.21. Track DAEWON PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is DAEWON PHARMACEUTICAL there?
Today DAEWON PHARMACEUTICAL has the market capitalization of 299.85 B, it has increased by 0.42% over the last week.
Yes, you can track DAEWON PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
DAEWON PHARMACEUTICAL revenue for the last quarter amounts to 156.80 B KRW, despite the estimated figure of 157.40 B KRW. In the next quarter, revenue is expected to reach 156.55 B KRW.
003220 net income for the last quarter is 6.79 B KRW, while the quarter before that showed −765.41 M KRW of net income which accounts for 986.64% change. Track more DAEWON PHARMACEUTICAL financial stats to get the full picture.
Yes, 003220 dividends are paid annually. The last dividend per share was 300.00 KRW. As of today, Dividend Yield (TTM)% is 2.14%. Tracking DAEWON PHARMACEUTICAL dividends might help you take more informed decisions.
DAEWON PHARMACEUTICAL dividend yield was 1.92% in 2023, and payout ratio reached 26.32%. The year before the numbers were 1.87% and 23.18% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has 1.22 K employees. See our rating of the largest employees — is DAEWON PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DAEWON PHARMACEUTICAL EBITDA is 50.55 B KRW, and current EBITDA margin is 9.45%. See more stats in DAEWON PHARMACEUTICAL financial statements.
Like other stocks, 003220 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DAEWON PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DAEWON PHARMACEUTICAL technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DAEWON PHARMACEUTICAL stock shows the sell signal. See more of DAEWON PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.